引用本文:周子婷,葛 菲(综述),蒋爱梅(审校).趋化因子CXCL16/CXCR6轴与乳腺癌相关关系的研究进展[J].中国临床新医学,2020,13(6):631-635.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1831次   下载 1377 本文二维码信息
码上扫一扫!
分享到: 微信 更多
趋化因子CXCL16/CXCR6轴与乳腺癌相关关系的研究进展
周子婷,葛 菲(综述),蒋爱梅(审校)
650032 云南,昆明医科大学第一附属医院乳腺外科
摘要:
[摘要] 乳腺癌是中老年女性发病率及病死率高居首位的恶性肿瘤,且呈年轻化趋势。乳腺癌发生、发展过程受诸多因素调控,其病因及发病机制尚未完全清楚。该文旨在对趋化因子CXCL16/CXCR6轴的结构、功能及其在乳腺癌发生、发展、侵袭过程中调控作用进行综述,为乳腺癌的分子生物学研究及靶向抗肿瘤治疗提供新思路。
关键词:  趋化因子  CXC型趋化因子配体16  细胞表面趋化因子受体6  乳腺癌
DOI:10.3969/j.issn.1674-3806.2020.06.24
分类号:R 737.9
基金项目:国家自然科学基金项目(编号:81660438)
Research progress of CXCL16/CXCR6 axis in breast cancer
ZHOU Zi-ting, GE Fei, JIANG Ai-mei
Department of Breast Surgery, the First Affiliated Hospital of Kunming Medical University, Yunnan 650032, China
Abstract:
[Abstract] Breast cancer is a malignant tumor with the highest morbidity and mortality among middle-aged and elderly women, and the patients who get this cancer become younger and younger. The occurrence and development of breast cancer are regulated by many factors, and its etiology and pathogenesis are not completely clear. This paper aims to investigate the structure and function of the Chemokine(C-X-C motif) ligand 16(CXCL16)/C-X-C chemokine receptor type 6(CXCR6) axis and its regulatory role in the occurrence, development and invasion of breast cancer, and to provide a review of new ideas for molecular biological research and targeted anti-tumor therapy of breast cancer.
Key words:  Chemokines(CK)  Chemokine(C-X-C motif) ligand 16(CXCL16)  C-X-C chemokine receptor type 6(CXCR6)  Breast cancer